Mucopolysaccharidosis (MPS) — NDIS Support
Yes — Mucopolysaccharidosis (MPS) can qualify for NDIS support. MPS is on the NDIA’s List B — permanence is recognised, and you evidence the functional impact on daily life. Funding covers reasonable and necessary supports across daily living, therapy, social participation and capacity building.
Mucopolysaccharidosis (MPS) is a group of rare, inherited metabolic conditions in which the body is missing an enzyme needed to break down complex sugar molecules called glycosaminoglycans. Without enough of the enzyme, these molecules build up in cells throughout the body, gradually damaging…
MPS & the NDIS FAQs
- Is MPS eligible for the NDIS?
- MPS is a permanent, progressive condition, so it can meet the NDIS disability requirements based on substantial functional impact. It is assessed on evidence rather than being automatically listed, so a specialist diagnosis confirming the type and its permanence, along with functional assessments of mobility,…
- Does the NDIS fund enzyme replacement therapy?
- No. Enzyme replacement therapy, bone marrow transplant and other medical treatments are funded through the health system, not the NDIS. The NDIS funds disability supports that build and maintain function and independence — such as therapy, support workers, assistive technology and home modifications — while the…
- How should plans account for the condition progressing?
- Because MPS is progressive, plans work best when they anticipate change rather than only reflecting current needs. Working with an occupational therapist and support coordinator to plan ahead for mobility equipment, home modifications and increasing personal care means supports are ready before they become urgent.…
- Can children with MPS access early support?
- Yes. Many types of MPS are diagnosed in early childhood, and children under seven can access the NDIS early childhood approach. Early physiotherapy, occupational therapy and equipment help maintain movement and participation, and early support also helps families understand and plan for the condition's course from the…
- What supports help most day to day?
- Physiotherapy and occupational therapy help maintain movement and manage joint and skeletal changes, while assistive technology and home modifications support mobility and safety. Support workers assist with personal care and community access, and in the neuronopathic types, communication and behaviour supports become…
MPS & the NDIS — practical guides
- Applying for the NDIS with Mucopolysaccharidosis (MPS)
- Assistive Technology for Mucopolysaccharidosis (MPS)
- Day Programs & Community Participation for Mucopolysaccharidosis (MPS)
- NDIS Funding & Budget for Mucopolysaccharidosis (MPS)
- Therapy & Allied Health for Mucopolysaccharidosis (MPS)
- Finding & Managing Support Workers for Mucopolysaccharidosis (MPS)
Related conditions
- Multiple System Atrophy (MSA) and the NDIS
- Myasthenia Gravis and the NDIS
- Osteogenesis Imperfecta and the NDIS
- Pitt-Hopkins Syndrome and the NDIS
- Post-Polio Syndrome and the NDIS
- Postural Orthostatic Tachycardia Syndrome (POTS) and the NDIS
- Progressive Supranuclear Palsy (PSP) and the NDIS
- Scleroderma (Systemic Sclerosis) and the NDIS
- Scoliosis (Severe / Neuromuscular) and the NDIS
- Sotos Syndrome and the NDIS
Sources
Reviewed by the Novida editorial team · last reviewed 2026-07-12. General information only — not medical advice.